Arterra Bioscience
ARBS.MI · MIL
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €0 | €0 | €0 | €0 |
| - Cash | €0 | €0 | €0 | €0 |
| + Debt | €0 | €0 | €0 | €0 |
| Enterprise Value | €0 | €0 | €0 | €0 |
| Revenue | €0 | €0 | €0 | €0 |
| % Growth | 25.1% | -7.1% | -24.3% | – |
| Gross Profit | €0 | €0 | €0 | €0 |
| % Margin | 87.5% | 55.5% | 13.7% | 14.2% |
| EBITDA | €0 | €0 | €0 | €0 |
| % Margin | 48.9% | 55.3% | 65.1% | 37.3% |
| Net Income | €0 | €0 | €0 | €0 |
| % Margin | 32% | 32.3% | 39.4% | 23.4% |
| EPS Diluted | 0.2 | 0.16 | 0.21 | 0.17 |
| % Growth | 25% | -23.8% | 23.5% | – |
| Operating Cash Flow | €0 | €0 | €0 | €0 |
| Capital Expenditures | -€0 | -€0 | -€0 | -€0 |
| Free Cash Flow | €0 | €0 | €0 | €0 |